Despite these challenges, CA-125 continues to play a crucial role in the clinical management of ovarian cancer patients, guiding diagnostic workups, treatment selection based on the specific characteristics of the cancer, and the patient’s overall health and disease monitoring. Here, MUC16 is linked to ovarian carcinoma.